Mark Versavel
Fondatore presso Vzenium LLC
Posizioni attive di Mark Versavel
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| Vzenium LLC | Fondatore | - | - |
| Presidente | - | - |
Storia della carriera di Mark Versavel
Precedenti posizioni note di Mark Versavel
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| ELIEM THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 01/03/2023 | 01/10/2023 |
Cavion, Inc.
 Cavion, Inc. Pharmaceuticals: MajorHealth Technology Cavion, Inc. engages in development of pharmaceuticals products. It produces oncology drugs to treat solid tumors that selectively inhibits the t-type calcium channel. The company was founded by Andrew J. Krouse, Lloyd S. Gray, and Timothy L. Macdonald in 2005 and is headquartered in Charlottesville, VA. | Direttore Tecnico/Scientifico/R&S | - | - |
| NEUROBO PHARMACEUTICALS, INC. | Direttore Tecnico/Scientifico/R&S | 31/12/2019 | - |
| ALZHEON, INC. | Direttore Tecnico/Scientifico/R&S | - | - |
Formazione di Mark Versavel
| University of Michigan | Masters Business Admin |
| Humboldt-Universität zu Berlin | Doctorate Degree |
| University of Antwerp | Doctorate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 7 |
| Germania | 2 |
| Belgio | 2 |
Posizioni
| Chief Tech/Sci/R&D Officer | 4 |
| Doctorate Degree | 2 |
| Masters Business Admin | 1 |
Settori
| Health Technology | 5 |
| Consumer Services | 4 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| ELIEM THERAPEUTICS, INC. | Health Technology |
| NEUROBO PHARMACEUTICALS, INC. | Health Technology |
| Aziende private | 3 |
|---|---|
Cavion, Inc.
Cavion, Inc. Pharmaceuticals: MajorHealth Technology Cavion, Inc. engages in development of pharmaceuticals products. It produces oncology drugs to treat solid tumors that selectively inhibits the t-type calcium channel. The company was founded by Andrew J. Krouse, Lloyd S. Gray, and Timothy L. Macdonald in 2005 and is headquartered in Charlottesville, VA. | Health Technology |
Alzheon, Inc.
 Alzheon, Inc. BiotechnologyHealth Technology Alzheon, Inc. engages in the provision of medical development. It specializes in treatment for brain health, memory, and aging. It offers ALZ-801, an oral small molecule inhibitor of amyloid formation and neurotoxicity with potential to be a therapy for a genetically defined population of patients with or at high risk for Alzheimer's disease and other neurodegenerative disorders. The company was founded by Martin Tolar in June 2013 and is headquartered in Framingham, MA. | Health Technology |
| Vzenium LLC |
- Borsa valori
- Insiders
- Mark Versavel
- Esperienza
